Vitalibis, Inc.

As of September 30, 2020, Vitalibis, Inc. carries a market capitalization of 779.83M, placing it among publicly traded companies globally. Its enterprise value stands at 779.82M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2020, Vitalibis, Inc. has 216.63M shares outstanding.

These figures are as of September 30, 2020. The price-to-sales ratio is 948.09, and the price-to-book ratio stands at -522.50.

These figures are as of September 30, 2020. The EV/Sales ratio of 3,201.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 779.82M versus a market cap of 779.83M, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2020, Vitalibis, Inc. maintains a current ratio of 5.03, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2020. Return on assets (ROA) is negative at -844.72, reflecting losses generated across the asset base. The company generates approximately 243,570.00 in revenue per employee across its workforce of 1.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.35 indicates how many times Vitalibis, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 5, 2026, Vitalibis, Inc.'s stock has declined approximately 95.25% over the past 52 weeks. The 50-day moving average sits at 2.52, while the 200-day moving average is 2.76.

Over the twelve months ended September 30, 2020, Vitalibis, Inc. generated 243,570.00 in revenue and converted that into -3.96M in net income, yielding earnings per share of -0.02. EBITDA reached -2.59M, while operating income came in at -2.65M.

These figures are as of September 30, 2020. Total book value stands at -1.49M, with working capital of 292,463.00 providing operational flexibility.

Vitalibis, Inc. produced -368,614.00 in operating cash flow over the twelve months ended September 30, 2020. After subtracting - - in capital expenditures, free cash flow totaled -368,614.00 - equivalent to -0.01 per share.

Over the twelve months ended September 30, 2020, Vitalibis, Inc. posted a gross margin of 51.56, reflecting its pricing power and cost economics. The operating margin of -1,088.48 and net profit margin of -1,624.14 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2020. Free cash flow yield is negative at -0.04: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.04, meaning Vitalibis, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Vitalibis, Inc.'s most recent stock split took place on June 15, 2026.

As of September 30, 2020, Vitalibis, Inc. has an Altman Z-Score of 180.59, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.